Lafora's disease, a rare progressive myoclonic epilepsy inherited on an aut
osomal recessive basis, typically starts in adolescence. The diagnosis rest
s on clinical grounds and is confirmed by the demonstration of Lafora bodie
s in the brain, skeletal muscle, and/or skin. The disease is caused by a mu
tation in a tyrosine phosphatase gene recently mapped to chromosome 6. The
case is reported of an 18-year-old Tunisian woman with progressive myocloni
c epilepsy. Generalized seizures and myoclonus had first appeared at 14 yea
rs of age. Intellectual function had deteriorated slowly and the patient wa
s no longer able to attend school. Her parents were consanguineous and five
of her cousins had died before the age of 20 years with similar manifestat
ions. An electro-encephalogram showed slow background activity with bilater
al symmetric discharges of spikes and polyspike-waves. A skin biopsy in the
axillary region demonstrated the round or oval PAS-positive inclusions kno
wn as Lafora's bodies in the basal region of the apocrine glands. Although
Lafora's disease is uncommon, it should be considered in every patient with
progressive myoclonic epilepsy, and a skin biopsy should be done at the sl
ightest doubt to look fbr Lafora's bodies.